ProfessorMD Anderson Cancer Center, United States
Disclosure information not submitted.
547 - Data Submitted for IR Devices Seeking FDA 510(k) Approval: Quality and Implications for Patient Safety
Monday, April 13, 202612:10 PM - 1:10 PM ET
338 - Phase I Trial of Cryoablation and Immunotherapy in Patients with Adaptive Immunotherapy Resistance, the CEDAR Trial: Cryoablation Challenge Evaluated in Adaptive-Immune Resistance
Wednesday, April 15, 202611:42 AM - 11:51 AM ET
